List view / Grid view

Manufacturing

 

article

‘Magic bullets’ for all: democratising biologics by rethinking antibody development, manufacturing and delivery

31 August 2021 | By ,

Antibody therapeutics revolutionised how diseases like cancer are treated in the developed world, but their high manufacturing cost and cumbersome distribution and administration leave them out of reach for most. In this guest article, Lumen Bioscience’s CEO, Brian Finrow, and EVP of Production & Development, Craig Behnke, discuss how new…